Xeris Biopharma Holdings Debt-to-Assets Ratio Growth & History (XERS)
Xeris Biopharma Holdings's debt-to-assets ratio was 0.67 for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual debt-to-assets ratio history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.67 | −0.17 | −19.91% |
| 2024 | 2024-12-31 | 0.84 | 0.13 | +18.27% |
| 2023 | 2023-12-31 | 0.71 | 0.14 | +23.58% |
| 2022 | 2022-12-31 | 0.57 | 0.29 | +98.68% |
| 2021 | 2021-12-31 | 0.29 | −0.26 | −47.08% |
| 2020 | 2020-12-31 | 0.55 | — | — |
Xeris Biopharma Holdings quarterly debt-to-assets ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.70 | −0.07 | −8.57% |
| Q1 2026 | 2026-03-31 | 0.66 | −0.19 | −22.58% |
| Q4 2025 | 2025-12-31 | 0.67 | −0.17 | −19.91% |
| Q3 2025 | 2025-09-30 | 0.70 | −0.10 | −12.67% |
| Q2 2025 | 2025-06-30 | 0.77 | −0.04 | −5.50% |
| Q1 2025 | 2025-03-31 | 0.85 | — | — |
| Q4 2024 | 2024-12-31 | 0.84 | 0.13 | +18.27% |
| Q3 2024 | 2024-09-30 | 0.80 | 0.10 | +14.60% |
| Q2 2024 | 2024-06-30 | 0.81 | — | — |
| Q4 2023 | 2023-12-31 | 0.71 | 0.14 | +23.58% |
| Q3 2023 | 2023-09-30 | 0.70 | 0.24 | +52.14% |
| Q4 2022 | 2022-12-31 | 0.57 | 0.29 | +98.68% |
| Q3 2022 | 2022-09-30 | 0.46 | −0.21 | −31.60% |
| Q2 2022 | 2022-06-30 | 0.43 | — | — |
| Q1 2022 | 2022-03-31 | 0.41 | — | — |
| Q4 2021 | 2021-12-31 | 0.29 | −0.26 | −47.08% |
| Q3 2021 | 2021-09-30 | 0.67 | — | — |
| Q4 2020 | 2020-12-31 | 0.55 | — | — |
Xeris Biopharma Holdings debt-to-assets ratio trends
Over the last five fiscal years, Xeris Biopharma Holdings's debt-to-assets ratio increased from 0.55 to 0.67, a change of 0.13. The latest reported quarter, Q2 2026, shows 0.70.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings source filings ↗